To decipher the molecular mechanism, we reconstituted the expression of IRF4 in CLL cells by using a Doxycycline (Dox) inducible IRF4-transgenic model (IRF4−/−Vh1IRF4Tg) (Figure S5). This evidence concerns the gene IRF4 and B-cell chronic lymphocytic leukemia.